Previous Close | 0.0700 |
Open | 0.0700 |
Bid | 0.0000 |
Ask | 0.3500 |
Strike | 60.00 |
Expire Date | 2024-01-19 |
Day's Range | 0.0700 - 0.0700 |
Contract Range | N/A |
Volume | |
Open Interest | 1.77k |
FOSTER CITY, Calif. / ACCESSWIRE / December 6, 2023 / Gilead Sciences, Inc. (NASDAQ:GILD) announced it will present new data at San Antonio Breast Cancer Symposium (SABCS) 2023, supporting the use of Trodelvy® (sacituzumab govitecan-hziy) in certain ...
Key Insights Given the large stake in the stock by institutions, Gilead Sciences' stock price might be vulnerable to...
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...